.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Follicular Lymphoma: Evolving Treatment Landscape

EP. 1: Diagnosis and Prognosis of Follicular Lymphoma

January 19th 2019

EP. 2: Risk Assessment in Follicular Lymphoma

January 19th 2019

EP. 3: Up-Front Therapy in Follicular Lymphoma

January 19th 2019

EP. 4: Treatment Options for High-Risk Follicular Lymphoma Cases

January 19th 2019

EP. 5: Maintenance Therapy and MRD Testing in Follicular Lymphoma

January 19th 2019

EP. 6: Treating Relapsed or Refractory Follicular Lymphoma

January 19th 2019

EP. 7: Third-Line Treatments and Transplantation

January 19th 2019

EP. 8: Use of PI3K Inhibitors in Relapsed Follicular Lymphoma

January 19th 2019

EP. 9: Long-Term Efficacy and Safety of Copanlisib

January 19th 2019

EP. 10: Strategies for Therapeutic Sequencing Agents

January 19th 2019

EP. 11: Potential of R2 Regimen in Treating Follicular Lymphoma

January 19th 2019

EP. 12: Immunotherapeutic Agents Against Follicular Lymphoma

January 19th 2019

EP. 13: Emerging Therapies and Combinations

January 19th 2019

EP. 14: Cause for Optimism in Follicular Lymphoma Treatment

January 19th 2019